Go Pro

Jasper Therapeutics (JSPRW) News Today

Jasper Therapeutics logo
$0.0099 +0.00 (+6.49%)
As of 09/2/2026 03:59 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Jasper Therapeutics Latest News

JSPRW - Jasper Therapeutics, Inc. WT EXP 092426
Jasper Therapeutics Inc. Wt
JSPR Share News Today
Jasper Therapeutics Inc : JSPRW
JSPRW Jasper Therapeutics, Inc. WT EXP 092426
TD Cowen Remains a Buy on Jasper Therapeutics (JSPR)
Jasper Therapeutics, Inc. (JSPRW) - Yahoo Finance
RBC Capital Sticks to Their Buy Rating for Jasper Therapeutics (JSPR)
Jasper Therapeutics (JSPR) Gets a Buy from UBS
Jasper Therapeutics (Nasdaq:JSPRW) Headline
Trading was temporarily halted for "JSPRW" at 07:01 PM with a stated reason of "News pending."...
Jasper Therapeutics (JSPR) Receives a Buy from Credit Suisse

Jasper Therapeutics Media Mentions By Week

Jasper Therapeutics Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

JSPRW
News Sentiment

0.00

0.78

Average
Healthcare
News Sentiment

Jasper Therapeutics News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

JSPRW Articles
This Week

0

1

JSPRW Articles
Average Week

Jasper Therapeutics Trends on MarketBeat

This week vs. last week
Page Views
521
-2%
Get Jasper Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for JSPRW and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Jasper Therapeutics dated 8/27/2026.
From Our Partners